-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"The past 2021 has been a year for the company to accumulate strength
.
We have made important upgrades in equipment and hardware, and have also made major breakthroughs in the field of testing.
Sales performance has risen sharply, production capacity has continued to increase, the workforce has been enriched and expanded, and strategic goals have been clear.
Gao Yuan
.
" This is a succinct summary from a pharmaceutical equipment industry company
.
And there are many pharmaceutical machine companies that are full of joy and passion like this
.
The pharmaceutical equipment industry in 2021 is a year of steady growth as a whole, and companies represented by Chutian Technology and Tofflon have achieved a lot
.
The 2021 annual report performance forecast shows that Chutian Technology expects a net profit of 500 million yuan to 600 million yuan in 2021, a year-on-year increase of 149.
33%-199.
2%; Tofflon pre-earnings 765 million yuan to 904 million yuan, a year-on-year increase of 65%-95%
.
Pharmaceutical equipment (Source: Pharmaceutical Network) Entering 2022, the pharmaceutical equipment industry is poised for development
.
The new year has just started, and the pharmaceutical machine companies are busy with orders
.
For example, a drying equipment company said that since the New Year's Day, the company's sales have continued to improve, and market orders for spray dryers, vibrating fluidized beds, vibrating fluidized beds, and hot air circulation ovens have come one after another, and the shipment volume has continued to increase; recently, a pharmaceutical company in Jinan There is also news from the machine company: the micro-leakage non-destructive sealer independently developed by the company has been tested and used by customers and has successfully passed the acceptance
.
According to reports, the equipment adopts the principle of vacuum decay method, which has high precision and fast test efficiency.
After the test, the sample is not damaged and does not affect normal use.
Another masterpiece in the field, which will provide favorable help for pharmaceutical companies to deal with drug consistency evaluation
.
From the perspective of market demand, the demand for high-level automation, environmental protection and energy saving, and high-end pharmaceutical equipment is growing.
.
Among them, in terms of automation, with the advancement of policies such as centralized procurement, pharmaceutical companies are generally faced with challenges in terms of capacity improvement and cost control.
High automation equipment is conducive to solving the bottleneck of pharmaceutical companies; in terms of environmental protection and energy conservation, China's biopharmaceutical industry is rapidly developing Under the development, industry supervision and standards are becoming more and more strict, and pharmaceutical companies need to face the discharge problems such as waste water and waste gas caused by the drug production process, which will drive the market demand for pharmaceutical environmental protection equipment to grow; in addition, emerging drugs are constantly rising, requiring high-end pharmaceuticals Equipment support
.
It can be said that the current pharmaceutical equipment industry is facing a situation of coexistence of opportunities and challenges.
Enterprises need to seize new trends in the market and grasp the new needs of users in order to better meet the development needs of pharmaceutical companies
.
In addition, judging from the potential of the pharmaceutical equipment market, domestic pharmaceutical equipment companies are expected to accelerate their layout in the high-end market and import substitution, and gain more room for growth
.
In recent years, pharmaceutical machine giants, including Chutian Technology, have seized new opportunities for development to actively deploy in the high-end pharmaceutical machine market, and many small and medium-sized enterprises plan to transform to high-end in the new year.
The domestic high-end pharmaceutical machine market will usher in further growth
.
In terms of domestic substitution, opportunities have also begun to emerge.
Especially in the past two years, when the delivery date of imported equipment has been delayed, powerful domestic pharmaceutical machine companies have gradually been favored and recognized by pharmaceutical companies.
Innovation and upgrading are accelerated, and it is expected that there will be a huge space for replacing imported equipment
.
.
We have made important upgrades in equipment and hardware, and have also made major breakthroughs in the field of testing.
Sales performance has risen sharply, production capacity has continued to increase, the workforce has been enriched and expanded, and strategic goals have been clear.
Gao Yuan
.
" This is a succinct summary from a pharmaceutical equipment industry company
.
And there are many pharmaceutical machine companies that are full of joy and passion like this
.
The pharmaceutical equipment industry in 2021 is a year of steady growth as a whole, and companies represented by Chutian Technology and Tofflon have achieved a lot
.
The 2021 annual report performance forecast shows that Chutian Technology expects a net profit of 500 million yuan to 600 million yuan in 2021, a year-on-year increase of 149.
33%-199.
2%; Tofflon pre-earnings 765 million yuan to 904 million yuan, a year-on-year increase of 65%-95%
.
Pharmaceutical equipment (Source: Pharmaceutical Network) Entering 2022, the pharmaceutical equipment industry is poised for development
.
The new year has just started, and the pharmaceutical machine companies are busy with orders
.
For example, a drying equipment company said that since the New Year's Day, the company's sales have continued to improve, and market orders for spray dryers, vibrating fluidized beds, vibrating fluidized beds, and hot air circulation ovens have come one after another, and the shipment volume has continued to increase; recently, a pharmaceutical company in Jinan There is also news from the machine company: the micro-leakage non-destructive sealer independently developed by the company has been tested and used by customers and has successfully passed the acceptance
.
According to reports, the equipment adopts the principle of vacuum decay method, which has high precision and fast test efficiency.
After the test, the sample is not damaged and does not affect normal use.
Another masterpiece in the field, which will provide favorable help for pharmaceutical companies to deal with drug consistency evaluation
.
From the perspective of market demand, the demand for high-level automation, environmental protection and energy saving, and high-end pharmaceutical equipment is growing.
.
Among them, in terms of automation, with the advancement of policies such as centralized procurement, pharmaceutical companies are generally faced with challenges in terms of capacity improvement and cost control.
High automation equipment is conducive to solving the bottleneck of pharmaceutical companies; in terms of environmental protection and energy conservation, China's biopharmaceutical industry is rapidly developing Under the development, industry supervision and standards are becoming more and more strict, and pharmaceutical companies need to face the discharge problems such as waste water and waste gas caused by the drug production process, which will drive the market demand for pharmaceutical environmental protection equipment to grow; in addition, emerging drugs are constantly rising, requiring high-end pharmaceuticals Equipment support
.
It can be said that the current pharmaceutical equipment industry is facing a situation of coexistence of opportunities and challenges.
Enterprises need to seize new trends in the market and grasp the new needs of users in order to better meet the development needs of pharmaceutical companies
.
In addition, judging from the potential of the pharmaceutical equipment market, domestic pharmaceutical equipment companies are expected to accelerate their layout in the high-end market and import substitution, and gain more room for growth
.
In recent years, pharmaceutical machine giants, including Chutian Technology, have seized new opportunities for development to actively deploy in the high-end pharmaceutical machine market, and many small and medium-sized enterprises plan to transform to high-end in the new year.
The domestic high-end pharmaceutical machine market will usher in further growth
.
In terms of domestic substitution, opportunities have also begun to emerge.
Especially in the past two years, when the delivery date of imported equipment has been delayed, powerful domestic pharmaceutical machine companies have gradually been favored and recognized by pharmaceutical companies.
Innovation and upgrading are accelerated, and it is expected that there will be a huge space for replacing imported equipment
.
